Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
14.6M
-
Shares change
-
-654K
-
Total reported value, excl. options
-
$72.9M
-
Value change
-
-$3.28M
-
Number of buys
-
14
-
Number of sells
-
-18
-
Price
-
$5.00
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q2 2018
47 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q2 2018.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.6M shares
of 386M outstanding shares and own 3.78% of the company stock.
Largest 10 shareholders include Paradice Investment Management LLC (1.64M shares), Russell Investments Group, Ltd. (1.44M shares), JANUS HENDERSON GROUP PLC (1.4M shares), Lapides Asset Management, LLC (1.24M shares), FIRST WILSHIRE SECURITIES MANAGEMENT INC (1.03M shares), Senvest Management, LLC (1M shares), 22NW, LP (954K shares), HEARTLAND ADVISORS INC (865K shares), Boston Partners (836K shares), and HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (774K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.